Tesamorelin
Public supplier report and marketplace listing from UWA Biotech.
Supplier testing information
Product overview
Tesamorelin is a growth hormone releasing hormone (GHRH) analogue supplied by UWA Biotech for laboratory investigations involving growth hormone signalling pathways, endocrine research, peptide receptor activity and metabolic research applications.
Available formats
- 10 × 5mg
- 10 × 10mg
- 10 × 20mg
- MOQ: 10 vials / 1 box
Verification
- Purity: 99.564%
- Tested: 26 FEB 2026
- Task number: #110153
- Unique key: RK19ACLG1K9U
Research applications
- Growth hormone pathway studies
- GHRH analogue research
- Endocrine signalling investigations
- Metabolic pathway research
This product is supplied exclusively for laboratory research use. Not for human consumption, therapeutic use or clinical application.
Tesamorelin laboratory testing questions
What is this Tesamorelin report?
This report contains publicly accessible batch testing information for Tesamorelin, including task number #110153, reported purity results, and Janoshik-linked laboratory reference data.
Has this Tesamorelin batch been laboratory tested?
Yes. This Tesamorelin batch includes publicly accessible laboratory testing references, including reported purity result 99.564%, task number #110153, and laboratory reference key RK19ACLG1K9U.
Who supplied this Tesamorelin batch?
UWA Biotech supplied this Tesamorelin batch from United States, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this Tesamorelin batch?
The reported purity result for this Tesamorelin batch was 99.564%.
Where can I view additional Tesamorelin reports?
Additional Tesamorelin laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.